Literature DB >> 7814476

Ribosomal DNA internal transcribed spacer analysis supports synonomy of Scedosporium inflatum and Lomentospora prolificans.

P A Lennon1, C R Cooper, I F Salkin, S B Lee.   

Abstract

Scedosporium inflatum is a dematiaceous opportunistic pathogen originally described by D. Malloch and I.F. Salkin (Mycotaxon 21:247-255, 1984). However, E. Gueho and G. S. De Hoog (J. Mycol. Med. 118:3-9, 1991) recently suggested reducing this mold to synonomy with Lomentospora prolificans on the basis of their similar morphological and molecular characteristics. We have investigated the ribosomal DNA internal transcribed spacers (ITS), i.e., ITS I and ITS II, of 18 isolates, including these two fungi and a closely related pathogen, Scedosporium apiospermum, and its telemorph, Pseudallescheria boydii. Identical ITS restriction fragment length polymorphisms were found in eight isolates of S. inflatum and L. prolificans. These results support Gueho and De Hoog's proposal to combine S. inflatum and L. prolificans into the binomial Scedosporium prolificans. However, the ITS I sequence of S. apiospermum and the ITS restriction fragment length polymorphisms of S. apiospermum and P. boydii were found to be significantly different from those of S. inflatum and L. prolificans. The ITS restriction pattern differences may be valuable in clinical settings for distinguishing these fungi.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814476      PMCID: PMC264076          DOI: 10.1128/jcm.32.10.2413-2416.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia.

Authors:  J Marin; M A Sanz; G F Sanz; J Guarro; M L Martínez; M Prieto; E Gueho; J L Menezo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

2.  Scedosporium inflatum, an emerging pathogen.

Authors:  I F Salkin; M R McGinnis; M J Dykstra; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

3.  Microwave miniprep of total genomic DNA from fungi, plants, protists and animals for PCR.

Authors:  D C Goodwin; S B Lee
Journal:  Biotechniques       Date:  1993-09       Impact factor: 1.993

4.  Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms.

Authors:  R D Vincent; R Goewert; W E Goldman; G S Kobayashi; A M Lambowitz; G Medoff
Journal:  J Bacteriol       Date:  1986-03       Impact factor: 3.490

5.  Epidemiologic study by DNA typing of a Candida albicans outbreak in heroin addicts.

Authors:  K V Clemons; G S Shankland; M D Richardson; D A Stevens
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

6.  Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum.

Authors:  E D Spitzer; B A Lasker; S J Travis; G S Kobayashi; G Medoff
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

7.  Analysis of restriction profiles of mitochondrial DNA from Sporothrix schenckii and related fungi.

Authors:  K Suzuki; M Kawasaki; H Ishizaki
Journal:  Mycopathologia       Date:  1988-09       Impact factor: 2.574

8.  Scedosporium inflatum: clinical spectrum of a newly recognized pathogen.

Authors:  C M Wilson; E J O'Rourke; M R McGinnis; I F Salkin
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

9.  Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis.

Authors:  D M Dixon; I F Salkin; R A Duncan; N J Hurd; J H Haines; M E Kemna; F B Coles
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  7 in total

1.  Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis.

Authors:  Alain Defontaine; Rachid Zouhair; Bernard Cimon; Jacqueline Carrère; Eric Bailly; Françoise Symoens; Mohammed Diouri; Jean-Noel Hallet; Jean-Philippe Bouchara
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Molecular variability of Pseudallescheria boydii, a neurotropic opportunist.

Authors:  J Rainer; G S de Hoog; M Wedde; Y Gräser; S Gilges
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients.

Authors:  Mariana Elizondo-Zertuche; Alexandra M Montoya; Efrén Robledo-Leal; Idalia Garza-Veloz; Ana L Sánchez-Núñez; Raquel Ballesteros-Elizondo; Gloria M González
Journal:  Mycopathologia       Date:  2017-04-29       Impact factor: 2.574

Review 4.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

5.  PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi.

Authors:  T J Walsh; A Francesconi; M Kasai; S J Chanock
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

6.  Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients.

Authors:  M Alvarez; B Lopez Ponga; C Rayon; J Garcia Gala; M C Roson Porto; M Gonzalez; J V Martinez-Suarez; J L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 7.  Lomentospora prolificans endocarditis--case report and literature review.

Authors:  Melissa Kelly; Robert Stevens; Pamela Konecny
Journal:  BMC Infect Dis       Date:  2016-01-29       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.